

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 9.71501377 |
| 2 | B cell receptor signaling pathway (GO:0050853) | 9.49130118 |
| 3 | positive regulation of B cell differentiation (GO:0045579) | 8.29909314 |
| 4 | regulation of gamma-delta T cell differentiation (GO:0045586) | 7.40669660 |
| 5 | serine transport (GO:0032329) | 7.29434122 |
| 6 | L-serine transport (GO:0015825) | 7.00990310 |
| 7 | regulation of gamma-delta T cell activation (GO:0046643) | 6.79670074 |
| 8 | V(D)J recombination (GO:0033151) | 6.39953092 |
| 9 | regulation of B cell differentiation (GO:0045577) | 6.34972509 |
| 10 | regulation of superoxide anion generation (GO:0032928) | 6.30759725 |
| 11 | neutrophil activation involved in immune response (GO:0002283) | 5.90838215 |
| 12 | regulation of histone H3-K9 methylation (GO:0051570) | 5.64696910 |
| 13 | neutrophil activation (GO:0042119) | 5.52375731 |
| 14 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 5.44527639 |
| 15 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 5.40434662 |
| 16 | positive regulation of mast cell degranulation (GO:0043306) | 5.40434662 |
| 17 | regulation of platelet aggregation (GO:0090330) | 5.29162177 |
| 18 | lymph vessel development (GO:0001945) | 5.25972020 |
| 19 | granulocyte activation (GO:0036230) | 4.89047439 |
| 20 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 4.72751969 |
| 21 | negative regulation of histone methylation (GO:0031061) | 4.68925794 |
| 22 | macrophage activation involved in immune response (GO:0002281) | 4.66938033 |
| 23 | positive regulation of cell adhesion mediated by integrin (GO:0033630) | 4.61524344 |
| 24 | B cell proliferation (GO:0042100) | 4.47897275 |
| 25 | hepatocyte apoptotic process (GO:0097284) | 4.44245630 |
| 26 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.38668007 |
| 27 | positive regulation of mast cell activation (GO:0033005) | 4.38141797 |
| 28 | antibacterial humoral response (GO:0019731) | 4.31752751 |
| 29 | natural killer cell differentiation (GO:0001779) | 4.31336093 |
| 30 | negative regulation of phagocytosis (GO:0050765) | 4.29149843 |
| 31 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.27302763 |
| 32 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 4.24341492 |
| 33 | positive regulation of bone resorption (GO:0045780) | 4.18474399 |
| 34 | positive regulation of bone remodeling (GO:0046852) | 4.18474399 |
| 35 | antimicrobial humoral response (GO:0019730) | 4.15199561 |
| 36 | mucosal-associated lymphoid tissue development (GO:0048537) | 4.12607208 |
| 37 | Peyers patch development (GO:0048541) | 4.12607208 |
| 38 | regulation of alpha-beta T cell proliferation (GO:0046640) | 4.09569858 |
| 39 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 4.06991020 |
| 40 | vesicle targeting (GO:0006903) | 4.06871848 |
| 41 | cellular response to zinc ion (GO:0071294) | 4.03076828 |
| 42 | germ cell migration (GO:0008354) | 3.98845267 |
| 43 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.91977055 |
| 44 | positive regulation of leukocyte degranulation (GO:0043302) | 3.91856802 |
| 45 | T cell homeostasis (GO:0043029) | 3.87660046 |
| 46 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.82332032 |
| 47 | regulation of antigen processing and presentation (GO:0002577) | 3.82217706 |
| 48 | regulation of superoxide metabolic process (GO:0090322) | 3.80499475 |
| 49 | negative thymic T cell selection (GO:0045060) | 3.74111564 |
| 50 | immunoglobulin mediated immune response (GO:0016064) | 3.73454423 |
| 51 | negative regulation of bone resorption (GO:0045779) | 3.73260156 |
| 52 | negative T cell selection (GO:0043383) | 3.69298127 |
| 53 | positive T cell selection (GO:0043368) | 3.68373750 |
| 54 | DNA deamination (GO:0045006) | 3.68188832 |
| 55 | regulation of germinal center formation (GO:0002634) | 3.62926034 |
| 56 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.61767533 |
| 57 | cellular hyperosmotic response (GO:0071474) | 3.60691187 |
| 58 | positive regulation by host of viral transcription (GO:0043923) | 3.59724172 |
| 59 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.59242022 |
| 60 | L-fucose catabolic process (GO:0042355) | 3.55477232 |
| 61 | fucose catabolic process (GO:0019317) | 3.55477232 |
| 62 | L-fucose metabolic process (GO:0042354) | 3.55477232 |
| 63 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.54218609 |
| 64 | regulation of mast cell degranulation (GO:0043304) | 3.52025944 |
| 65 | lymphocyte homeostasis (GO:0002260) | 3.51696210 |
| 66 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.47553300 |
| 67 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.47553300 |
| 68 | negative regulation of B cell proliferation (GO:0030889) | 3.46105452 |
| 69 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.45067893 |
| 70 | somatic cell DNA recombination (GO:0016444) | 3.44321874 |
| 71 | somatic diversification of immune receptors via germline recombination within a single locus (GO:000 | 3.44321874 |
| 72 | tachykinin receptor signaling pathway (GO:0007217) | 3.41238457 |
| 73 | positive regulation of antigen processing and presentation (GO:0002579) | 3.40949603 |
| 74 | T cell selection (GO:0045058) | 3.40816242 |
| 75 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.40329201 |
| 76 | nucleosome disassembly (GO:0006337) | 3.40007321 |
| 77 | protein-DNA complex disassembly (GO:0032986) | 3.40007321 |
| 78 | positive regulation of granulocyte differentiation (GO:0030854) | 3.37885634 |
| 79 | regulation of MHC class I biosynthetic process (GO:0045343) | 3.37498811 |
| 80 | activated T cell proliferation (GO:0050798) | 3.33457944 |
| 81 | response to protozoan (GO:0001562) | 3.32604282 |
| 82 | regulation of icosanoid secretion (GO:0032303) | 3.32054922 |
| 83 | adaptation of signaling pathway (GO:0023058) | 3.29373612 |
| 84 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.29260603 |
| 85 | positive regulation of gene expression, epigenetic (GO:0045815) | 3.28050133 |
| 86 | regulation of B cell proliferation (GO:0030888) | 3.26798951 |
| 87 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 3.24544016 |
| 88 | positive regulation of protein homooligomerization (GO:0032464) | 3.24134746 |
| 89 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.23241307 |
| 90 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.23241307 |
| 91 | negative regulation of cell killing (GO:0031342) | 3.22840055 |
| 92 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.22840055 |
| 93 | positive regulation of B cell activation (GO:0050871) | 3.22415868 |
| 94 | B cell differentiation (GO:0030183) | 3.20387316 |
| 95 | cellular response to exogenous dsRNA (GO:0071360) | 3.20075580 |
| 96 | myelin maintenance (GO:0043217) | 3.19728391 |
| 97 | positive regulation of defense response to virus by host (GO:0002230) | 3.19458952 |
| 98 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.18040215 |
| 99 | cellular response to interleukin-15 (GO:0071350) | 3.16935538 |
| 100 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.16414434 |
| 101 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.16282191 |
| 102 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.13945420 |
| 103 | somatic diversification of immune receptors (GO:0002200) | 3.13150873 |
| 104 | B cell activation (GO:0042113) | 3.12323718 |
| 105 | regulation of homotypic cell-cell adhesion (GO:0034110) | 3.11547169 |
| 106 | tolerance induction (GO:0002507) | 3.10348200 |
| 107 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002 | 3.10230752 |
| 108 | Fc-gamma receptor signaling pathway (GO:0038094) | 3.10230752 |
| 109 | Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096) | 3.10230752 |
| 110 | response to interleukin-15 (GO:0070672) | 3.07238536 |
| 111 | activation of JUN kinase activity (GO:0007257) | 3.07137782 |
| 112 | leukotriene biosynthetic process (GO:0019370) | 3.07014975 |
| 113 | Fc receptor mediated stimulatory signaling pathway (GO:0002431) | 3.05510131 |
| 114 | mitotic chromosome condensation (GO:0007076) | 3.03882640 |
| 115 | B cell homeostasis (GO:0001782) | 3.03876814 |
| 116 | leukocyte homeostasis (GO:0001776) | 3.03809751 |
| 117 | regulation of B cell apoptotic process (GO:0002902) | 3.01848692 |
| 118 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.00913299 |
| 119 | negative regulation of mast cell activation (GO:0033004) | 3.00678420 |
| 120 | mature B cell differentiation (GO:0002335) | 3.00553609 |
| 121 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.00540572 |
| 122 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.97057578 |
| 123 | positive regulation of alpha-beta T cell differentiation (GO:0046638) | 2.95625659 |
| 124 | DNA topological change (GO:0006265) | 2.94880095 |
| 125 | thymic T cell selection (GO:0045061) | 2.94578633 |
| 126 | negative regulation of bone remodeling (GO:0046851) | 2.94236912 |
| 127 | defense response to protozoan (GO:0042832) | 2.91860970 |
| 128 | mononuclear cell proliferation (GO:0032943) | 2.91821318 |
| 129 | detection of bacterium (GO:0016045) | 2.91216994 |
| 130 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.90848086 |
| 131 | leukocyte aggregation (GO:0070486) | 2.90536128 |
| 132 | positive thymic T cell selection (GO:0045059) | 2.89781620 |
| 133 | lymphocyte proliferation (GO:0046651) | 2.89469536 |
| 134 | mast cell activation (GO:0045576) | 2.86848406 |
| 135 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.86663146 |
| 136 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.86646022 |
| 137 | regulation of histone methylation (GO:0031060) | 2.86057029 |
| 138 | regulation of bone resorption (GO:0045124) | 2.85179288 |
| 139 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.85004256 |
| 140 | B cell mediated immunity (GO:0019724) | 2.84034261 |
| 141 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.83981053 |
| 142 | interferon-gamma production (GO:0032609) | 2.82722552 |
| 143 | regulation of mast cell activation (GO:0033003) | 2.81621024 |
| 144 | positive regulation of interferon-alpha production (GO:0032727) | 2.80840670 |
| 145 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.80199766 |
| 146 | negative regulation of T cell mediated immunity (GO:0002710) | 2.78167761 |
| 147 | positive regulation of B cell proliferation (GO:0030890) | 2.77378761 |
| 148 | detection of other organism (GO:0098543) | 2.76890009 |
| 149 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.75887259 |
| 150 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.75645859 |
| 151 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.73935540 |
| 152 | mast cell activation involved in immune response (GO:0002279) | 2.72834277 |
| 153 | mast cell degranulation (GO:0043303) | 2.72834277 |
| 154 | positive regulation by symbiont of host defense response (GO:0052509) | 2.69608997 |
| 155 | modulation by symbiont of host defense response (GO:0052031) | 2.69608997 |
| 156 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.69608997 |
| 157 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.69608997 |
| 158 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.69608997 |
| 159 | modulation by symbiont of host immune response (GO:0052553) | 2.69608997 |
| 160 | regulation of interferon-alpha production (GO:0032647) | 2.69271660 |
| 161 | response to type I interferon (GO:0034340) | 2.69041104 |
| 162 | cytidine metabolic process (GO:0046087) | 2.65012480 |
| 163 | cytidine catabolic process (GO:0006216) | 2.65012480 |
| 164 | cytidine deamination (GO:0009972) | 2.65012480 |
| 165 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.62804118 |
| 166 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.61439828 |
| 167 | negative regulation of adaptive immune response (GO:0002820) | 2.60968359 |
| 168 | cellular response to type I interferon (GO:0071357) | 2.59603633 |
| 169 | type I interferon signaling pathway (GO:0060337) | 2.59603633 |
| 170 | regulation of defense response to virus by host (GO:0050691) | 2.58840158 |
| 171 | indolalkylamine metabolic process (GO:0006586) | 2.58247850 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.57599614 |
| 2 | MYC_22102868_ChIP-Seq_BL_Human | 4.83593145 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.79649219 |
| 4 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.94869026 |
| 5 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.87683638 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.71419388 |
| 7 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.68383857 |
| 8 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 3.42624433 |
| 9 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.29838566 |
| 10 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.83597033 |
| 11 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.79102893 |
| 12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.64811179 |
| 13 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.61667335 |
| 14 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.56169568 |
| 15 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.50813526 |
| 16 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.44275521 |
| 17 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.34319719 |
| 18 | MAF_26560356_Chip-Seq_TH1_Human | 2.31524010 |
| 19 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.24129084 |
| 20 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.20707838 |
| 21 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.15072745 |
| 22 | * UTX_26944678_Chip-Seq_JUKART_Human | 2.13702213 |
| 23 | MYB_26560356_Chip-Seq_TH2_Human | 2.10417070 |
| 24 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.10253300 |
| 25 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.07700517 |
| 26 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.06195867 |
| 27 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.01239367 |
| 28 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 10.4684968 |
| 29 | MYB_26560356_Chip-Seq_TH1_Human | 1.98941522 |
| 30 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.96239688 |
| 31 | GATA3_26560356_Chip-Seq_TH2_Human | 1.92573763 |
| 32 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.89780175 |
| 33 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.87163761 |
| 34 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.83315131 |
| 35 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.81877342 |
| 36 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.81254717 |
| 37 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.78853397 |
| 38 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.77703283 |
| 39 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.75068313 |
| 40 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.73278605 |
| 41 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.64693323 |
| 42 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.64338341 |
| 43 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.62022479 |
| 44 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.61567042 |
| 45 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.61232509 |
| 46 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.59471030 |
| 47 | VDR_22108803_ChIP-Seq_LS180_Human | 1.58451009 |
| 48 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.56506219 |
| 49 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.54447564 |
| 50 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.48720370 |
| 51 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.45390431 |
| 52 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.45214281 |
| 53 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.42751350 |
| 54 | SPI1_23127762_ChIP-Seq_K562_Human | 1.42062560 |
| 55 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.40451830 |
| 56 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.40433514 |
| 57 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.39545596 |
| 58 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.36621593 |
| 59 | GATA1_22025678_ChIP-Seq_K562_Human | 1.36010657 |
| 60 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.35119004 |
| 61 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.33607261 |
| 62 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.31410578 |
| 63 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.30444984 |
| 64 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.30045076 |
| 65 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28492092 |
| 66 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.28340087 |
| 67 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.28004424 |
| 68 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.26781742 |
| 69 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.26197280 |
| 70 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.26040045 |
| 71 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.25344316 |
| 72 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.24721462 |
| 73 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.22112473 |
| 74 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.20699559 |
| 75 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.19798386 |
| 76 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.19022644 |
| 77 | MAF_26560356_Chip-Seq_TH2_Human | 1.18548410 |
| 78 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 1.17784940 |
| 79 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.16434262 |
| 80 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.16418564 |
| 81 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.15079338 |
| 82 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.14431727 |
| 83 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.13256190 |
| 84 | GATA3_26560356_Chip-Seq_TH1_Human | 1.13035418 |
| 85 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.12158523 |
| 86 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.11993472 |
| 87 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11815326 |
| 88 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.11756303 |
| 89 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.11470742 |
| 90 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.10548696 |
| 91 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.10061585 |
| 92 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.10044906 |
| 93 | EWS_26573619_Chip-Seq_HEK293_Human | 1.09128283 |
| 94 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.08921638 |
| 95 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.08149753 |
| 96 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.07476523 |
| 97 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.05318739 |
| 98 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.05318739 |
| 99 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.02528093 |
| 100 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.01904303 |
| 101 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.01851719 |
| 102 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.01238733 |
| 103 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.00941950 |
| 104 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.00514031 |
| 105 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.99893707 |
| 106 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.99317269 |
| 107 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.99230958 |
| 108 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.99230958 |
| 109 | ERA_21632823_ChIP-Seq_H3396_Human | 0.98441876 |
| 110 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.98388578 |
| 111 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.98303863 |
| 112 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.98293670 |
| 113 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97496300 |
| 114 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.97480821 |
| 115 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.97176163 |
| 116 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96694817 |
| 117 | TCF4_23295773_ChIP-Seq_U87_Human | 0.96168162 |
| 118 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.96048493 |
| 119 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.94825600 |
| 120 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.94223694 |
| 121 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.93859710 |
| 122 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.93085134 |
| 123 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.92950893 |
| 124 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92850621 |
| 125 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.91362238 |
| 126 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89933240 |
| 127 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.89876533 |
| 128 | STAT3_23295773_ChIP-Seq_U87_Human | 0.89793182 |
| 129 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.89638040 |
| 130 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.88954129 |
| 131 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.84838476 |
| 132 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.82319739 |
| 133 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.79654036 |
| 134 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.78496157 |
| 135 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.77660968 |
| 136 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.75754180 |
| 137 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.74729016 |
| 138 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.73496479 |
| 139 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.73118589 |
| 140 | GATA1_19941826_ChIP-Seq_K562_Human | 0.72791362 |
| 141 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.71981931 |
| 142 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.70781978 |
| 143 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.68973500 |
| 144 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.68502900 |
| 145 | P300_27268052_Chip-Seq_Bcells_Human | 0.68438055 |
| 146 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.67729679 |
| 147 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.67139683 |
| 148 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.64648145 |
| 149 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.63867386 |
| 150 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.63851883 |
| 151 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.63292693 |
| 152 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.62173608 |
| 153 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.61135437 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001800_abnormal_humoral_immune | 4.63571739 |
| 2 | MP0001835_abnormal_antigen_presentation | 4.26587914 |
| 3 | MP0006054_spinal_hemorrhage | 4.07631966 |
| 4 | MP0001790_abnormal_immune_system | 3.96197521 |
| 5 | MP0005387_immune_system_phenotype | 3.96197521 |
| 6 | MP0000685_abnormal_immune_system | 3.87735801 |
| 7 | MP0003303_peritoneal_inflammation | 3.68264525 |
| 8 | MP0002452_abnormal_antigen_presenting | 3.54030933 |
| 9 | MP0002166_altered_tumor_susceptibility | 3.19921582 |
| 10 | MP0002398_abnormal_bone_marrow | 3.06920549 |
| 11 | MP0002420_abnormal_adaptive_immunity | 2.85231054 |
| 12 | MP0002723_abnormal_immune_serum | 2.84365395 |
| 13 | MP0001819_abnormal_immune_cell | 2.78165784 |
| 14 | MP0000689_abnormal_spleen_morphology | 2.76232315 |
| 15 | MP0005000_abnormal_immune_tolerance | 2.74962715 |
| 16 | MP0002396_abnormal_hematopoietic_system | 2.72531710 |
| 17 | MP0000716_abnormal_immune_system | 2.67119703 |
| 18 | MP0005671_abnormal_response_to | 2.59701576 |
| 19 | MP0002722_abnormal_immune_system | 2.42122957 |
| 20 | MP0003724_increased_susceptibility_to | 2.41439765 |
| 21 | MP0004808_abnormal_hematopoietic_stem | 2.26362302 |
| 22 | MP0002006_tumorigenesis | 2.21944025 |
| 23 | MP0002429_abnormal_blood_cell | 2.20595605 |
| 24 | MP0000703_abnormal_thymus_morphology | 2.20127719 |
| 25 | MP0003436_decreased_susceptibility_to | 2.19331668 |
| 26 | MP0005075_abnormal_melanosome_morpholog | 2.18323377 |
| 27 | MP0001879_abnormal_lymphatic_vessel | 2.17015226 |
| 28 | MP0001986_abnormal_taste_sensitivity | 2.14460025 |
| 29 | MP0003300_gastrointestinal_ulcer | 2.08462428 |
| 30 | MP0003646_muscle_fatigue | 2.08363200 |
| 31 | MP0009785_altered_susceptibility_to | 1.80042670 |
| 32 | MP0005025_abnormal_response_to | 1.79806952 |
| 33 | MP0003763_abnormal_thymus_physiology | 1.76174284 |
| 34 | MP0010234_abnormal_vibrissa_follicle | 1.74974676 |
| 35 | MP0000465_gastrointestinal_hemorrhage | 1.65876940 |
| 36 | MP0010155_abnormal_intestine_physiology | 1.63797209 |
| 37 | MP0010094_abnormal_chromosome_stability | 1.60456446 |
| 38 | MP0004043_abnormal_pH_regulation | 1.56939821 |
| 39 | MP0008057_abnormal_DNA_replication | 1.53219860 |
| 40 | MP0005645_abnormal_hypothalamus_physiol | 1.52532290 |
| 41 | MP0002019_abnormal_tumor_incidence | 1.51183093 |
| 42 | MP0010352_gastrointestinal_tract_polyps | 1.49464762 |
| 43 | MP0004947_skin_inflammation | 1.48339661 |
| 44 | MP0002405_respiratory_system_inflammati | 1.47649303 |
| 45 | MP0002419_abnormal_innate_immunity | 1.47055791 |
| 46 | MP0009278_abnormal_bone_marrow | 1.44852533 |
| 47 | MP0002653_abnormal_ependyma_morphology | 1.41996348 |
| 48 | MP0003172_abnormal_lysosome_physiology | 1.38360913 |
| 49 | MP0003787_abnormal_imprinting | 1.38072780 |
| 50 | MP0002933_joint_inflammation | 1.37875092 |
| 51 | MP0009764_decreased_sensitivity_to | 1.37640562 |
| 52 | MP0001845_abnormal_inflammatory_respons | 1.36345019 |
| 53 | MP0003195_calcinosis | 1.35528202 |
| 54 | MP0004381_abnormal_hair_follicle | 1.30939150 |
| 55 | MP0003866_abnormal_defecation | 1.26515708 |
| 56 | MP0001873_stomach_inflammation | 1.26299169 |
| 57 | MP0003252_abnormal_bile_duct | 1.24395927 |
| 58 | MP0003077_abnormal_cell_cycle | 1.22724957 |
| 59 | MP0002148_abnormal_hypersensitivity_rea | 1.22145229 |
| 60 | MP0008872_abnormal_physiological_respon | 1.21772154 |
| 61 | MP0003183_abnormal_peptide_metabolism | 1.12460146 |
| 62 | MP0005551_abnormal_eye_electrophysiolog | 1.08976760 |
| 63 | MP0000372_irregular_coat_pigmentation | 1.06990879 |
| 64 | MP0006082_CNS_inflammation | 1.04964576 |
| 65 | MP0004142_abnormal_muscle_tone | 1.03937824 |
| 66 | MP0001968_abnormal_touch/_nociception | 1.03164927 |
| 67 | MP0005076_abnormal_cell_differentiation | 0.99205412 |
| 68 | MP0001501_abnormal_sleep_pattern | 0.98739049 |
| 69 | MP0002095_abnormal_skin_pigmentation | 0.98666802 |
| 70 | MP0000490_abnormal_crypts_of | 0.97909698 |
| 71 | MP0002009_preneoplasia | 0.97141823 |
| 72 | MP0002693_abnormal_pancreas_physiology | 0.94684583 |
| 73 | MP0002132_abnormal_respiratory_system | 0.94307728 |
| 74 | MP0005464_abnormal_platelet_physiology | 0.93925185 |
| 75 | MP0003111_abnormal_nucleus_morphology | 0.93491559 |
| 76 | MP0008961_abnormal_basal_metabolism | 0.93333839 |
| 77 | MP0001853_heart_inflammation | 0.91843027 |
| 78 | MP0005397_hematopoietic_system_phenotyp | 0.91516164 |
| 79 | MP0001545_abnormal_hematopoietic_system | 0.91516164 |
| 80 | MP0000350_abnormal_cell_proliferation | 0.91237239 |
| 81 | MP0002136_abnormal_kidney_physiology | 0.90493883 |
| 82 | MP0004510_myositis | 0.85765137 |
| 83 | MP0003091_abnormal_cell_migration | 0.84470943 |
| 84 | MP0000569_abnormal_digit_pigmentation | 0.83708157 |
| 85 | MP0005084_abnormal_gallbladder_morpholo | 0.83457660 |
| 86 | MP0002102_abnormal_ear_morphology | 0.80966075 |
| 87 | MP0002876_abnormal_thyroid_physiology | 0.80405050 |
| 88 | MP0005310_abnormal_salivary_gland | 0.79901132 |
| 89 | MP0003045_fibrosis | 0.79007982 |
| 90 | MP0001915_intracranial_hemorrhage | 0.77129132 |
| 91 | MP0003453_abnormal_keratinocyte_physiol | 0.77031315 |
| 92 | MP0003279_aneurysm | 0.76061789 |
| 93 | MP0003693_abnormal_embryo_hatching | 0.74891979 |
| 94 | MP0001764_abnormal_homeostasis | 0.70713549 |
| 95 | MP0002928_abnormal_bile_duct | 0.70335376 |
| 96 | MP0005501_abnormal_skin_physiology | 0.69329539 |
| 97 | MP0009931_abnormal_skin_appearance | 0.68682484 |
| 98 | MP0005621_abnormal_cell_physiology | 0.68661712 |
| 99 | MP0005253_abnormal_eye_physiology | 0.68087662 |
| 100 | MP0004883_abnormal_blood_vessel | 0.67696034 |
| 101 | MP0003566_abnormal_cell_adhesion | 0.67554628 |
| 102 | MP0008877_abnormal_DNA_methylation | 0.67190832 |
| 103 | MP0009333_abnormal_splenocyte_physiolog | 0.66538077 |
| 104 | MP0009745_abnormal_behavioral_response | 0.66302160 |
| 105 | MP0000470_abnormal_stomach_morphology | 0.66215818 |
| 106 | MP0010307_abnormal_tumor_latency | 0.65341130 |
| 107 | MP0002163_abnormal_gland_morphology | 0.65245927 |
| 108 | MP0000313_abnormal_cell_death | 0.64856600 |
| 109 | MP0008469_abnormal_protein_level | 0.64689935 |
| 110 | MP0004885_abnormal_endolymph | 0.64360657 |
| 111 | MP0000371_diluted_coat_color | 0.63187181 |
| 112 | MP0008874_decreased_physiological_sensi | 0.62255387 |
| 113 | MP0000427_abnormal_hair_cycle | 0.62110665 |
| 114 | MP0001784_abnormal_fluid_regulation | 0.62010740 |
| 115 | MP0001533_abnormal_skeleton_physiology | 0.61587705 |
| 116 | MP0001919_abnormal_reproductive_system | 0.61335154 |
| 117 | MP0004130_abnormal_muscle_cell | 0.60928042 |
| 118 | MP0003656_abnormal_erythrocyte_physiolo | 0.60767518 |
| 119 | MP0002083_premature_death | 0.60530159 |
| 120 | MP0004742_abnormal_vestibular_system | 0.60520039 |
| 121 | MP0001730_embryonic_growth_arrest | 0.60496486 |
| 122 | MP0000733_abnormal_muscle_development | 0.59383489 |
| 123 | MP0004957_abnormal_blastocyst_morpholog | 0.58911349 |
| 124 | MP0001663_abnormal_digestive_system | 0.58832944 |
| 125 | MP0008007_abnormal_cellular_replicative | 0.58048607 |
| 126 | MP0002138_abnormal_hepatobiliary_system | 0.57741739 |
| 127 | MP0000249_abnormal_blood_vessel | 0.57302545 |
| 128 | MP0008995_early_reproductive_senescence | 0.56481683 |
| 129 | MP0004197_abnormal_fetal_growth/weight/ | 0.55499227 |
| 130 | MP0005389_reproductive_system_phenotype | 0.55116805 |
| 131 | MP0005167_abnormal_blood-brain_barrier | 0.54241274 |
| 132 | MP0002277_abnormal_respiratory_mucosa | 0.54217517 |
| 133 | MP0002638_abnormal_pupillary_reflex | 0.53199315 |
| 134 | MP0004484_altered_response_of | 0.53109447 |
| 135 | MP0010329_abnormal_lipoprotein_level | 0.52956211 |
| 136 | MP0004147_increased_porphyrin_level | 0.52801983 |
| 137 | MP0002060_abnormal_skin_morphology | 0.52661090 |
| 138 | MP0001849_ear_inflammation | 0.52263367 |
| 139 | MP0000015_abnormal_ear_pigmentation | 0.51630949 |
| 140 | MP0000767_abnormal_smooth_muscle | 0.50801245 |
| 141 | MP0005174_abnormal_tail_pigmentation | 0.50537828 |
| 142 | MP0003943_abnormal_hepatobiliary_system | 0.47907728 |
| 143 | MP0005384_cellular_phenotype | 0.47482464 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Agammaglobulinemia (HP:0004432) | 8.99398580 |
| 2 | Verrucae (HP:0200043) | 7.58947340 |
| 3 | Papilloma (HP:0012740) | 7.58947340 |
| 4 | B lymphocytopenia (HP:0010976) | 7.21828118 |
| 5 | Abnormality of B cell number (HP:0010975) | 7.21828118 |
| 6 | Cellulitis (HP:0100658) | 7.01136057 |
| 7 | Small epiphyses (HP:0010585) | 6.10980033 |
| 8 | Thyroiditis (HP:0100646) | 5.95671887 |
| 9 | Recurrent bronchitis (HP:0002837) | 5.47213322 |
| 10 | Gastrointestinal stroma tumor (HP:0100723) | 5.40214928 |
| 11 | Colitis (HP:0002583) | 5.23661096 |
| 12 | Recurrent viral infections (HP:0004429) | 5.21383690 |
| 13 | Panhypogammaglobulinemia (HP:0003139) | 5.20271321 |
| 14 | Recurrent sinusitis (HP:0011108) | 4.77747300 |
| 15 | Meningitis (HP:0001287) | 4.68764618 |
| 16 | Vertebral arch anomaly (HP:0008438) | 4.50335727 |
| 17 | Inflammation of the large intestine (HP:0002037) | 4.35304301 |
| 18 | Chronic sinusitis (HP:0011109) | 4.24165583 |
| 19 | Osteomyelitis (HP:0002754) | 4.24114463 |
| 20 | Gastrointestinal inflammation (HP:0004386) | 4.24066456 |
| 21 | Mitral stenosis (HP:0001718) | 4.14224526 |
| 22 | Sepsis (HP:0100806) | 4.02849391 |
| 23 | Hypoplasia of the thymus (HP:0000778) | 3.96965467 |
| 24 | Severe combined immunodeficiency (HP:0004430) | 3.96941729 |
| 25 | Abnormality of the intervertebral disk (HP:0005108) | 3.90873939 |
| 26 | Flattened epiphyses (HP:0003071) | 3.79544023 |
| 27 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 3.79490045 |
| 28 | Recurrent pneumonia (HP:0006532) | 3.70079431 |
| 29 | Combined immunodeficiency (HP:0005387) | 3.61490204 |
| 30 | Lymphopenia (HP:0001888) | 3.54764053 |
| 31 | Recurrent fungal infections (HP:0002841) | 3.48141224 |
| 32 | Ulnar bowing (HP:0003031) | 3.41428058 |
| 33 | T lymphocytopenia (HP:0005403) | 3.40201511 |
| 34 | IgM deficiency (HP:0002850) | 3.40096026 |
| 35 | Stomatitis (HP:0010280) | 3.39188426 |
| 36 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.38079670 |
| 37 | Recurrent otitis media (HP:0000403) | 3.37886123 |
| 38 | IgG deficiency (HP:0004315) | 3.28829615 |
| 39 | Congenital stationary night blindness (HP:0007642) | 3.23865891 |
| 40 | Abnormality of T cell number (HP:0011839) | 3.15382453 |
| 41 | Arthropathy (HP:0003040) | 3.14196467 |
| 42 | Emphysema (HP:0002097) | 3.11458107 |
| 43 | Recurrent lower respiratory tract infections (HP:0002783) | 3.10549940 |
| 44 | Encephalitis (HP:0002383) | 3.09159643 |
| 45 | Bronchitis (HP:0012387) | 3.07143618 |
| 46 | Pancreatic cysts (HP:0001737) | 3.00889339 |
| 47 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 3.00792219 |
| 48 | Absent epiphyses (HP:0010577) | 3.00792219 |
| 49 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.93517197 |
| 50 | Eczematoid dermatitis (HP:0000976) | 2.89068562 |
| 51 | Irregular vertebral endplates (HP:0003301) | 2.85278830 |
| 52 | Stomach cancer (HP:0012126) | 2.83603484 |
| 53 | Eosinophilia (HP:0001880) | 2.79653499 |
| 54 | Optic neuritis (HP:0100653) | 2.78443537 |
| 55 | Retrobulbar optic neuritis (HP:0100654) | 2.78443537 |
| 56 | Myositis (HP:0100614) | 2.75887067 |
| 57 | Abnormality of T cell physiology (HP:0011840) | 2.75211683 |
| 58 | Restrictive lung disease (HP:0002091) | 2.70020499 |
| 59 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.66936644 |
| 60 | Vasculitis (HP:0002633) | 2.66085053 |
| 61 | Clumsiness (HP:0002312) | 2.61914046 |
| 62 | Attenuation of retinal blood vessels (HP:0007843) | 2.59593156 |
| 63 | Abnormality of the fingertips (HP:0001211) | 2.56817872 |
| 64 | Skin rash (HP:0000988) | 2.54951417 |
| 65 | Abnormality of the prostate (HP:0008775) | 2.53524933 |
| 66 | Hypoproteinemia (HP:0003075) | 2.46866392 |
| 67 | Orchitis (HP:0100796) | 2.46098352 |
| 68 | Pustule (HP:0200039) | 2.42827344 |
| 69 | Barrel-shaped chest (HP:0001552) | 2.41752913 |
| 70 | Molar tooth sign on MRI (HP:0002419) | 2.41461183 |
| 71 | Abnormality of midbrain morphology (HP:0002418) | 2.41461183 |
| 72 | Chronic otitis media (HP:0000389) | 2.40379521 |
| 73 | Vertebral clefting (HP:0008428) | 2.37099322 |
| 74 | Abnormality of T cells (HP:0002843) | 2.35934182 |
| 75 | Lymphoma (HP:0002665) | 2.35032974 |
| 76 | Abnormality of eosinophils (HP:0001879) | 2.32979612 |
| 77 | Limited elbow extension (HP:0001377) | 2.32743012 |
| 78 | Granulocytopenia (HP:0001913) | 2.31980795 |
| 79 | Gastrointestinal infarctions (HP:0005244) | 2.30866876 |
| 80 | Hyperventilation (HP:0002883) | 2.26568629 |
| 81 | Abnormality of the renal cortex (HP:0011035) | 2.21541664 |
| 82 | Obstructive lung disease (HP:0006536) | 2.18729923 |
| 83 | Chronic obstructive pulmonary disease (HP:0006510) | 2.18729923 |
| 84 | Autoimmune thrombocytopenia (HP:0001973) | 2.18134006 |
| 85 | Neutropenia (HP:0001875) | 2.18038409 |
| 86 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.17658234 |
| 87 | Pancreatic fibrosis (HP:0100732) | 2.17038980 |
| 88 | Pulmonary infiltrates (HP:0002113) | 2.15960252 |
| 89 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.15485658 |
| 90 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.14642604 |
| 91 | Bile duct proliferation (HP:0001408) | 2.13206799 |
| 92 | Abnormal biliary tract physiology (HP:0012439) | 2.13206799 |
| 93 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.12634183 |
| 94 | Abnormality of the vertebral endplates (HP:0005106) | 2.11670285 |
| 95 | Aqueductal stenosis (HP:0002410) | 2.10952017 |
| 96 | Abolished electroretinogram (ERG) (HP:0000550) | 2.09207293 |
| 97 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.06870463 |
| 98 | Recurrent cutaneous fungal infections (HP:0011370) | 2.06870463 |
| 99 | Hypochromic anemia (HP:0001931) | 2.05730231 |
| 100 | Keratoconjunctivitis (HP:0001096) | 2.05386602 |
| 101 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.04944100 |
| 102 | Hemoptysis (HP:0002105) | 2.04940762 |
| 103 | Chronic hepatic failure (HP:0100626) | 2.03861164 |
| 104 | Recurrent bacterial skin infections (HP:0005406) | 2.03783875 |
| 105 | Genetic anticipation (HP:0003743) | 2.03077034 |
| 106 | Protruding tongue (HP:0010808) | 2.02303387 |
| 107 | Mediastinal lymphadenopathy (HP:0100721) | 2.01954561 |
| 108 | Nephronophthisis (HP:0000090) | 1.99984088 |
| 109 | Recurrent abscess formation (HP:0002722) | 1.98195790 |
| 110 | Aortic regurgitation (HP:0001659) | 1.96857479 |
| 111 | Bowed forearm bones (HP:0003956) | 1.96848723 |
| 112 | Bowing of the arm (HP:0006488) | 1.96848723 |
| 113 | Gaze-evoked nystagmus (HP:0000640) | 1.95109855 |
| 114 | Prostate neoplasm (HP:0100787) | 1.94700211 |
| 115 | Facial diplegia (HP:0001349) | 1.93569969 |
| 116 | Skin ulcer (HP:0200042) | 1.93242704 |
| 117 | Abnormality of the pleura (HP:0002103) | 1.93129432 |
| 118 | Leukopenia (HP:0001882) | 1.92258361 |
| 119 | Hypochromic microcytic anemia (HP:0004840) | 1.91298432 |
| 120 | True hermaphroditism (HP:0010459) | 1.91023425 |
| 121 | IgA deficiency (HP:0002720) | 1.90720709 |
| 122 | Abnormality of macrophages (HP:0004311) | 1.90274242 |
| 123 | Volvulus (HP:0002580) | 1.90134132 |
| 124 | Abnormal drinking behavior (HP:0030082) | 1.89554571 |
| 125 | Polydipsia (HP:0001959) | 1.89554571 |
| 126 | Viral hepatitis (HP:0006562) | 1.88019266 |
| 127 | Dehydration (HP:0001944) | 1.87818797 |
| 128 | Cutis marmorata (HP:0000965) | 1.87707524 |
| 129 | Long eyelashes (HP:0000527) | 1.86529488 |
| 130 | Hematochezia (HP:0002573) | 1.85909772 |
| 131 | Keratoconjunctivitis sicca (HP:0001097) | 1.85907270 |
| 132 | Abnormality of the renal medulla (HP:0100957) | 1.85689114 |
| 133 | Prolonged bleeding time (HP:0003010) | 1.84673657 |
| 134 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.83864781 |
| 135 | Abnormality of carpal bone ossification (HP:0006257) | 1.82554838 |
| 136 | Abnormality of the tricuspid valve (HP:0001702) | 1.82494738 |
| 137 | Abnormality of the thymus (HP:0000777) | 1.78638494 |
| 138 | Acute lymphatic leukemia (HP:0006721) | 1.78576576 |
| 139 | Cutaneous melanoma (HP:0012056) | 1.78027475 |
| 140 | Cortical dysplasia (HP:0002539) | 1.75607973 |
| 141 | Leukocytosis (HP:0001974) | 1.72965683 |
| 142 | Recurrent skin infections (HP:0001581) | 1.72241785 |
| 143 | Abnormal ossification of hand bones (HP:0005921) | 1.71692316 |
| 144 | Cubitus valgus (HP:0002967) | 1.70500673 |
| 145 | Spontaneous hematomas (HP:0007420) | 1.66135052 |
| 146 | External ear malformation (HP:0008572) | 1.65862815 |
| 147 | Asymmetry of the thorax (HP:0001555) | 1.63713726 |
| 148 | Short femoral neck (HP:0100864) | 1.62372234 |
| 149 | Erythroderma (HP:0001019) | 1.62223040 |
| 150 | Abnormal hand bone ossification (HP:0010660) | 1.61231505 |
| 151 | Increased IgE level (HP:0003212) | 1.58234194 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K10 | 9.14962626 |
| 2 | GRK6 | 4.87366540 |
| 3 | TLK1 | 3.68744918 |
| 4 | MAP4K1 | 3.25881856 |
| 5 | ERN1 | 2.83055779 |
| 6 | TXK | 2.69297412 |
| 7 | STK4 | 2.51188710 |
| 8 | TAOK3 | 2.41170015 |
| 9 | RIPK4 | 2.24996795 |
| 10 | SYK | 2.20557009 |
| 11 | ADRBK2 | 2.14117134 |
| 12 | IRAK4 | 2.10031915 |
| 13 | ACVR1B | 2.09755110 |
| 14 | BLK | 1.96741479 |
| 15 | IKBKE | 1.84610622 |
| 16 | CSF1R | 1.82880798 |
| 17 | BTK | 1.82193240 |
| 18 | EEF2K | 1.77564926 |
| 19 | SIK2 | 1.74391920 |
| 20 | DYRK1B | 1.71034225 |
| 21 | CDK9 | 1.64854045 |
| 22 | BMPR1B | 1.62859575 |
| 23 | PIM1 | 1.53878334 |
| 24 | KIT | 1.53758847 |
| 25 | STK10 | 1.53014338 |
| 26 | FRK | 1.52598363 |
| 27 | ZAK | 1.50969606 |
| 28 | LRRK2 | 1.45424066 |
| 29 | LYN | 1.41844249 |
| 30 | BMPR2 | 1.39964970 |
| 31 | CDK12 | 1.35941602 |
| 32 | CDK4 | 1.34022874 |
| 33 | MAP4K2 | 1.29675945 |
| 34 | JAK3 | 1.27792580 |
| 35 | WNK4 | 1.27672233 |
| 36 | NUAK1 | 1.26209399 |
| 37 | TRIB3 | 1.24468456 |
| 38 | EIF2AK3 | 1.23685714 |
| 39 | DYRK3 | 1.21460659 |
| 40 | NEK2 | 1.20704120 |
| 41 | MAPK13 | 1.19850255 |
| 42 | MAPK7 | 1.14618580 |
| 43 | FES | 1.13836521 |
| 44 | MAP3K14 | 1.13351595 |
| 45 | FGFR2 | 1.12466027 |
| 46 | MAP2K1 | 1.09174156 |
| 47 | CSK | 1.06405739 |
| 48 | WNK1 | 1.05298954 |
| 49 | HCK | 1.05152011 |
| 50 | TYK2 | 1.02556231 |
| 51 | MAP3K8 | 1.00244586 |
| 52 | INSRR | 0.94367686 |
| 53 | CLK1 | 0.91686419 |
| 54 | RPS6KB2 | 0.90750091 |
| 55 | MAPK4 | 0.89651024 |
| 56 | RPS6KA5 | 0.88629018 |
| 57 | FGFR3 | 0.87831307 |
| 58 | PINK1 | 0.87801681 |
| 59 | TNK2 | 0.85773964 |
| 60 | PKN1 | 0.84095775 |
| 61 | OXSR1 | 0.83129852 |
| 62 | MATK | 0.82600168 |
| 63 | MARK3 | 0.80688478 |
| 64 | LCK | 0.79674602 |
| 65 | HIPK2 | 0.79393124 |
| 66 | PIK3CG | 0.78554228 |
| 67 | JAK1 | 0.77899975 |
| 68 | PRKD1 | 0.77678942 |
| 69 | ADRBK1 | 0.77567681 |
| 70 | IRAK1 | 0.76588085 |
| 71 | VRK1 | 0.75418154 |
| 72 | SIK1 | 0.73044844 |
| 73 | WNK3 | 0.72927744 |
| 74 | PKN2 | 0.70935699 |
| 75 | TBK1 | 0.68294058 |
| 76 | DAPK2 | 0.66637089 |
| 77 | MAP3K7 | 0.65910700 |
| 78 | PTK2B | 0.60550435 |
| 79 | MAP2K6 | 0.58897043 |
| 80 | MAP3K13 | 0.58381403 |
| 81 | CSNK1D | 0.58227201 |
| 82 | CAMKK2 | 0.57091416 |
| 83 | MAP3K11 | 0.56143477 |
| 84 | TESK2 | 0.55949729 |
| 85 | MELK | 0.55062893 |
| 86 | PRKCQ | 0.54359933 |
| 87 | MST4 | 0.54203386 |
| 88 | CDK3 | 0.53850024 |
| 89 | ITK | 0.52852992 |
| 90 | CDC42BPA | 0.52186405 |
| 91 | STK39 | 0.51663982 |
| 92 | FYN | 0.51327034 |
| 93 | PDK1 | 0.50936655 |
| 94 | ZAP70 | 0.50299008 |
| 95 | IKBKB | 0.50108438 |
| 96 | MAP2K2 | 0.49285296 |
| 97 | JAK2 | 0.48550697 |
| 98 | MAPK12 | 0.48288541 |
| 99 | FGR | 0.46126365 |
| 100 | AURKB | 0.46040218 |
| 101 | SCYL2 | 0.45687853 |
| 102 | TEC | 0.44728451 |
| 103 | BRD4 | 0.42790617 |
| 104 | CDK6 | 0.42339163 |
| 105 | RPS6KA6 | 0.42004420 |
| 106 | PRKD2 | 0.41047712 |
| 107 | SIK3 | 0.40552390 |
| 108 | TGFBR2 | 0.40239156 |
| 109 | MAPK11 | 0.40204850 |
| 110 | SGK2 | 0.39783067 |
| 111 | NLK | 0.39721173 |
| 112 | CHEK1 | 0.38820406 |
| 113 | CAMK1 | 0.37750207 |
| 114 | INSR | 0.37571577 |
| 115 | CAMKK1 | 0.36640141 |
| 116 | SGK3 | 0.36454261 |
| 117 | PRKAA1 | 0.34526164 |
| 118 | NTRK3 | 0.34013815 |
| 119 | CAMK4 | 0.31936248 |
| 120 | MAP3K4 | 0.30925604 |
| 121 | DYRK1A | 0.30550403 |
| 122 | PRKCZ | 0.28682944 |
| 123 | RPS6KB1 | 0.28575360 |
| 124 | PASK | 0.28195095 |
| 125 | STK11 | 0.27254812 |
| 126 | MUSK | 0.27218895 |
| 127 | EGFR | 0.27018187 |
| 128 | GRK1 | 0.26446515 |
| 129 | MARK2 | 0.26102402 |
| 130 | CHEK2 | 0.25297694 |
| 131 | STK16 | 0.25168132 |
| 132 | MAPK3 | 0.25149262 |
| 133 | PRKCH | 0.24364918 |
| 134 | MAP2K3 | 0.24087944 |
| 135 | CAMK1G | 0.24045852 |
| 136 | PRKAA2 | 0.23753257 |
| 137 | ABL1 | 0.23678293 |
| 138 | CDC7 | 0.22518717 |
| 139 | STK3 | 0.21758970 |
| 140 | RAF1 | 0.21073908 |
| 141 | ATR | 0.20461024 |
| 142 | PRKCD | 0.20227667 |
| 143 | ALK | 0.20154180 |
| 144 | CHUK | 0.19467359 |
| 145 | CAMK1D | 0.19326851 |
| 146 | PAK3 | 0.19206188 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 5.58978149 |
| 2 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 5.56607478 |
| 3 | Primary immunodeficiency_Homo sapiens_hsa05340 | 5.27136615 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 3.58601448 |
| 5 | Asthma_Homo sapiens_hsa05310 | 3.54964403 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.54551027 |
| 7 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.46327751 |
| 8 | Non-homologous end-joining_Homo sapiens_hsa03450 | 3.45089649 |
| 9 | Alcoholism_Homo sapiens_hsa05034 | 3.31174167 |
| 10 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.87204141 |
| 11 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.58092480 |
| 12 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.48633343 |
| 13 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.36685618 |
| 14 | Viral carcinogenesis_Homo sapiens_hsa05203 | 2.35996943 |
| 15 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.25304089 |
| 16 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 2.14156216 |
| 17 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.07249192 |
| 18 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.92406490 |
| 19 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.84274609 |
| 20 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.72270888 |
| 21 | Base excision repair_Homo sapiens_hsa03410 | 1.68444600 |
| 22 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.64104080 |
| 23 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.56787768 |
| 24 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.53228544 |
| 25 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.52547120 |
| 26 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.49382973 |
| 27 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.38757881 |
| 28 | Phototransduction_Homo sapiens_hsa04744 | 1.37833704 |
| 29 | Leishmaniasis_Homo sapiens_hsa05140 | 1.30079499 |
| 30 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.29162344 |
| 31 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.22700773 |
| 32 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.15448728 |
| 33 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.15298883 |
| 34 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.14923561 |
| 35 | Platelet activation_Homo sapiens_hsa04611 | 1.13769790 |
| 36 | Mismatch repair_Homo sapiens_hsa03430 | 1.10774782 |
| 37 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.09631443 |
| 38 | Tuberculosis_Homo sapiens_hsa05152 | 1.07991591 |
| 39 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.07432982 |
| 40 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.07392796 |
| 41 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.07135565 |
| 42 | Glioma_Homo sapiens_hsa05214 | 1.04611221 |
| 43 | Measles_Homo sapiens_hsa05162 | 1.03598282 |
| 44 | Hepatitis B_Homo sapiens_hsa05161 | 1.02930453 |
| 45 | ABC transporters_Homo sapiens_hsa02010 | 1.00279743 |
| 46 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.98851537 |
| 47 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.97647146 |
| 48 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.97086865 |
| 49 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.96930312 |
| 50 | DNA replication_Homo sapiens_hsa03030 | 0.96792632 |
| 51 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.93378581 |
| 52 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.92448738 |
| 53 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.92118742 |
| 54 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.90825036 |
| 55 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.90112890 |
| 56 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.89113486 |
| 57 | HTLV-I infection_Homo sapiens_hsa05166 | 0.85304791 |
| 58 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.84183895 |
| 59 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.83962698 |
| 60 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.83693957 |
| 61 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.83374363 |
| 62 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.79475318 |
| 63 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.78548192 |
| 64 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.77264197 |
| 65 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.75154577 |
| 66 | Apoptosis_Homo sapiens_hsa04210 | 0.74616916 |
| 67 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.74059785 |
| 68 | Shigellosis_Homo sapiens_hsa05131 | 0.73778983 |
| 69 | Morphine addiction_Homo sapiens_hsa05032 | 0.73465108 |
| 70 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.73299548 |
| 71 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.73190164 |
| 72 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.72501840 |
| 73 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.71913135 |
| 74 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.70975211 |
| 75 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.67870095 |
| 76 | Prostate cancer_Homo sapiens_hsa05215 | 0.67339895 |
| 77 | Influenza A_Homo sapiens_hsa05164 | 0.65561330 |
| 78 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.64768371 |
| 79 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.64307798 |
| 80 | Cell cycle_Homo sapiens_hsa04110 | 0.63902537 |
| 81 | Lysine degradation_Homo sapiens_hsa00310 | 0.61222756 |
| 82 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.61151390 |
| 83 | Insulin resistance_Homo sapiens_hsa04931 | 0.61049883 |
| 84 | Colorectal cancer_Homo sapiens_hsa05210 | 0.60771012 |
| 85 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.59940063 |
| 86 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.59270178 |
| 87 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.59210766 |
| 88 | Taste transduction_Homo sapiens_hsa04742 | 0.58530121 |
| 89 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.57582911 |
| 90 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.57184768 |
| 91 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.55724529 |
| 92 | Spliceosome_Homo sapiens_hsa03040 | 0.55265121 |
| 93 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.52740216 |
| 94 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.52499300 |
| 95 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.52035844 |
| 96 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.51575267 |
| 97 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.49186474 |
| 98 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.49009948 |
| 99 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.48729048 |
| 100 | Olfactory transduction_Homo sapiens_hsa04740 | 0.48088159 |
| 101 | Phagosome_Homo sapiens_hsa04145 | 0.48032890 |
| 102 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.48026066 |
| 103 | Homologous recombination_Homo sapiens_hsa03440 | 0.46827616 |
| 104 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.46291810 |
| 105 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.44822978 |
| 106 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.44620799 |
| 107 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.42708110 |
| 108 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.42675417 |
| 109 | Hepatitis C_Homo sapiens_hsa05160 | 0.41732558 |
| 110 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.41336803 |
| 111 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.40634146 |
| 112 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.40577379 |
| 113 | RNA polymerase_Homo sapiens_hsa03020 | 0.40502999 |
| 114 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.38932135 |
| 115 | Endocytosis_Homo sapiens_hsa04144 | 0.37730648 |
| 116 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.37498668 |
| 117 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.35409884 |
| 118 | Endometrial cancer_Homo sapiens_hsa05213 | 0.34319938 |
| 119 | Nicotine addiction_Homo sapiens_hsa05033 | 0.34262432 |
| 120 | RNA degradation_Homo sapiens_hsa03018 | 0.33228200 |
| 121 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.32131665 |
| 122 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.31549188 |
| 123 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.30999806 |
| 124 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.30824321 |
| 125 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.30703694 |
| 126 | Long-term depression_Homo sapiens_hsa04730 | 0.30693591 |
| 127 | Long-term potentiation_Homo sapiens_hsa04720 | 0.29703535 |
| 128 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.28892738 |
| 129 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.27954216 |
| 130 | Basal transcription factors_Homo sapiens_hsa03022 | 0.27731373 |
| 131 | Circadian entrainment_Homo sapiens_hsa04713 | 0.27436231 |
| 132 | Pertussis_Homo sapiens_hsa05133 | 0.27152571 |
| 133 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.26785634 |
| 134 | Salmonella infection_Homo sapiens_hsa05132 | 0.25996855 |
| 135 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.25630207 |
| 136 | Pathways in cancer_Homo sapiens_hsa05200 | 0.25351360 |
| 137 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.24828639 |
| 138 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.24379144 |
| 139 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.23923756 |
| 140 | Salivary secretion_Homo sapiens_hsa04970 | 0.22938828 |
| 141 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.21733404 |
| 142 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.21721736 |
| 143 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.21661191 |
| 144 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.21230528 |
| 145 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.21221437 |
| 146 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.21167965 |
| 147 | Ribosome_Homo sapiens_hsa03010 | 0.21163527 |
| 148 | Malaria_Homo sapiens_hsa05144 | 0.20462057 |
| 149 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.18018401 |
| 150 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.17158637 |
| 151 | Viral myocarditis_Homo sapiens_hsa05416 | 0.16384718 |

